Skip to main content
OpenTrials
Completed

NCT Number: NCT06691139

A Comparative Study of Temporalis Fascia Graft and Periosteal Graft in Myringoplasty

A Comparative Study of Temporalis Fascia Graft and Periosteal Graft in Myringoplasty

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Myringoplasty

Age range

12 year–40 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Sohag university hospital

Sohag, Egypt

About this study

The aim of this clinical trials is to asses and compare the surgical outcomes of Temporalis fascia graft and periosteal graft in myringoplasty in terms of graft intake and audiological improvement

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

age 12years to 40 years Small to moderate sized perforation . Dry tubotympanic chronic suppurative otitis media For more than 6 weeks .

Exclusion criteria

Active discharge or superimposed otomycosis . Patients with sensorineural hearing loss. Patients with considerable nasal pathology.

Treatment and study plan

Myringoplasty using periosteal graft and myringoplasty using Temporalis fascia graft in patients ages from 12 years to 40 years

Procedure

Myringoplasty using periosteal graft and myringoplasty using Temporalis fascia

Myringoplasty using Temporalis fascia graft and myringoplasty using periosteal graft

Other

Group (A) Myringoplasty using periosteal graft Group (B) Myringoplasty using Temporalis fascia graft

Myringoplasty operation using periosteal graft and myringoplasty using Temporalis fascia graft

Procedure

Myringoplasty using Temporalis fascia graft and myringoplasty using periosteal graft in age from 12years to 40 years

Group (A) myringoplasty using periosteal graft Group (B) Myringoplasty using Temporalis fascia graft

Procedure

Myringoplasty operation using Temporalis fascia graft and Myringoplasty using periosteal graft in patients from 12 years to 40 years

Primary outcomes

  1. hearing improvment

    Time frame: from January 2022 to January 2024

    outcome of temporalis fascia graft and periosteal graft for managment tympanic membrane perforation for audiological improvement

Sponsors and collaborators

Lead sponsor

Mohamed Soltan Nada

Other

Registry information

Important dates

Study start
2022
Primary completion
2024
Study completion
2024
First posted
Nov 15, 2024
Registry last updated
Nov 15, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.